Ralph R. Weichselbaum

Ludwig Cancer Research — Belgium

Medicine · Health Sciences

123h-index65.4kcitations1.3kworks10.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(134), Cancer Immunotherapy and Biomarkers(120), Effects of Radiation Exposure(89), Virus-based gene therapy research(86), Advanced Radiotherapy Techniques(78)

Publications1.3k total

Publisher Correction: Radiation-induced amphiregulin drives tumour metastasis
Nature·2025Open Access
Radiotherapy induces YTHDF2 in dendritic cells impairing cross-presentation and T cell function
The Journal of Experimental Medicine·2025Open Access
Enhanced clinical and systemic response with combination radiation therapy and topical imiquimod in mycosis fungoides: A pilot study
Blood·2025Open Access
Radiation-Induced Amphiregulin Drives Tumor Metastasis
International Journal of Radiation Oncology*Biology*Physics·2025
Amphiregulin as a Mediator of Radiation-Induced Systemic Effects in Metastatic Cancer: Balancing Local Control with Distant Progression
Clinical Cancer Research·2025
Correction: Suppression of local type I interferon by gut microbiota–derived butyrate impairs antitumor effects of ionizing radiation
The Journal of Experimental Medicine·2025Open Access
Azidothymidine Phosphate-Loaded Hafnium-Phthalocyanine Nanoscale Metal–Organic Framework for Enhanced Cancer Therapy
Chemistry of Materials·2025· 1 cited
Author response for "Light-Triggered Toll-Like Receptor Activation in a Nanoscale Metal–Organic Framework for Synergistic PDT and Cancer Immunotherapy"
2025
NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity
Nature·2025· 10 citedOpen Access
Nanoscale Donor–Acceptor Covalent Organic Frameworks for Mitochondria-Targeted Sonodynamic Therapy and Antitumor Immunity
Journal of the American Chemical Society·2025· 15 cited
A universal chimeric antigen receptor (CAR)–fragment antibody binder (FAB) split system for cancer immunotherapy
Science Advances·2025· 1 citedOpen Access
Tumor aneuploidy as a prognostic and predictive biomarker in immune checkpoint blockade
Nature Genetics·2025· 1 cited
YTHDFs as radiotherapy checkpoints in tumor immunity
The Journal of Experimental Medicine·2025· 1 cited
Synthesis of DOTA-Based 43Sc Radiopharmaceuticals Using Cyclotron-Produced 43Sc as Exemplified by [43Sc]Sc-PSMA-617 for PSMA PET Imaging
Methods and Protocols·2025· 1 citedOpen Access
Radiation-induced amphiregulin drives tumour metastasis
Nature·2025· 41 cited
Transforming malignant tumors into vulnerable phenotypes via nanoscale coordination polymer mediated cell senescence and photodynamic therapy
Biomaterials·2025· 1 citedOpen Access
Facts and Hopes in Radioimmunotherapy of Oligometastatic Disease
Clinical Cancer Research·2025· 4 cited
Abstract A024: Preclinical quantification of sources of solid tumor resistance onset: Hypoxia and immune exhaustion
Cancer Research·2025
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation
The Lancet Oncology·2025· 17 citedOpen Access
No disease left behind
Oncotarget·2025Open Access
page 1 of 64Next →

Frequent Co-authors

Yang‐Xin Fu(10), Hua Liang(8), Donald Küfe(8), Wenbin Lin(8), Michael A. Beckett(7), Nining Guo(7), Liufu Deng(6), Nikolai N. Khodarev(6), Christina Chan(6), Samuel Hellmän(5), Everett E. Vokes(5), Helena J. Mauceri(5), Surender Kharbanda(5), Joseph K. Salama(5), Byron Burnette(4), Thomas E. Darga(4), Meng Xu(4), Ainhoa Arina(4), Xiaona Huang(4), Kuangda Lu(4)